COVID-19 Impact on Global Intravenous Immune Globulin Therapies Market Size, Status and Forecast 2020-2026
Immune globulin derived from the plasma of paid and volunteer donors is used in the treatment of an array of disorders, including primary and secondary immune deficiency states and a variety of autoimmune and inflammatory disorders.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Intravenous Immune Globulin Therapies market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Intravenous Immune Globulin Therapies industry.
Based on our recent survey, we have several different scenarios about the Intravenous Immune Globulin Therapies YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Intravenous Immune Globulin Therapies will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Intravenous Immune Globulin Therapies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Intravenous Immune Globulin Therapies market in terms of revenue.
Players, stakeholders, and other participants in the global Intravenous Immune Globulin Therapies market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Intravenous Immune Globulin Therapies market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Intravenous Immune Globulin Therapies market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Intravenous Immune Globulin Therapies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Intravenous Immune Globulin Therapies market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Intravenous Immune Globulin Therapies market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Intravenous Immune Globulin Therapies industry.
Based on our recent survey, we have several different scenarios about the Intravenous Immune Globulin Therapies YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Intravenous Immune Globulin Therapies will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Intravenous Immune Globulin Therapies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Intravenous Immune Globulin Therapies market in terms of revenue.
Players, stakeholders, and other participants in the global Intravenous Immune Globulin Therapies market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Intravenous Immune Globulin Therapies market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Intravenous Immune Globulin Therapies market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Intravenous Immune Globulin Therapies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Intravenous Immune Globulin Therapies market.
The following players are covered in this report:
- Baxter
- Grifols
- CSL Plasma
- Octapharma
- Biotest
- Kedrion
- Kamada
- China Biologic Products Holdings
- Hualan Biological Engineering
- Sichuan Yuanda Shuyang Pharmaceutical
- Liquid Form
- Lyophilized Powder Form
- Immunodeficiency
- Autoimmune Disease
- Acute Infection
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Intravenous Immune Globulin Therapies Revenue
1.4 Market Analysis by Type
1.4.1 Global Intravenous Immune Globulin Therapies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Liquid Form
1.4.3 Lyophilized Powder Form
1.5 Market by Application
1.5.1 Global Intravenous Immune Globulin Therapies Market Share by Application: 2020 VS 2026
1.5.2 Immunodeficiency
1.5.3 Autoimmune Disease
1.5.4 Acute Infection
1.6 Coronavirus Disease 2019 (Covid-19): Intravenous Immune Globulin Therapies Industry Impact
1.6.1 How the Covid-19 is Affecting the Intravenous Immune Globulin Therapies Industry
1.6.1.1 Intravenous Immune Globulin Therapies Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Intravenous Immune Globulin Therapies Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Intravenous Immune Globulin Therapies Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Intravenous Immune Globulin Therapies Market Perspective (2015-2026)
2.2 Intravenous Immune Globulin Therapies Growth Trends by Regions
2.2.1 Intravenous Immune Globulin Therapies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Intravenous Immune Globulin Therapies Historic Market Share by Regions (2015-2020)
2.2.3 Intravenous Immune Globulin Therapies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Intravenous Immune Globulin Therapies Market Growth Strategy
2.3.6 Primary Interviews with Key Intravenous Immune Globulin Therapies Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Intravenous Immune Globulin Therapies Players by Market Size
3.1.1 Global Top Intravenous Immune Globulin Therapies Players by Revenue (2015-2020)
3.1.2 Global Intravenous Immune Globulin Therapies Revenue Market Share by Players (2015-2020)
3.1.3 Global Intravenous Immune Globulin Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Intravenous Immune Globulin Therapies Market Concentration Ratio
3.2.1 Global Intravenous Immune Globulin Therapies Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Intravenous Immune Globulin Therapies Revenue in 2019
3.3 Intravenous Immune Globulin Therapies Key Players Head office and Area Served
3.4 Key Players Intravenous Immune Globulin Therapies Product Solution and Service
3.5 Date of Enter into Intravenous Immune Globulin Therapies Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Intravenous Immune Globulin Therapies Historic Market Size by Type (2015-2020)
4.2 Global Intravenous Immune Globulin Therapies Forecasted Market Size by Type (2021-2026)
5 INTRAVENOUS IMMUNE GLOBULIN THERAPIES BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
5.2 Global Intravenous Immune Globulin Therapies Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Intravenous Immune Globulin Therapies Market Size (2015-2020)
6.2 Intravenous Immune Globulin Therapies Key Players in North America (2019-2020)
6.3 North America Intravenous Immune Globulin Therapies Market Size by Type (2015-2020)
6.4 North America Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Intravenous Immune Globulin Therapies Market Size (2015-2020)
7.2 Intravenous Immune Globulin Therapies Key Players in Europe (2019-2020)
7.3 Europe Intravenous Immune Globulin Therapies Market Size by Type (2015-2020)
7.4 Europe Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
8 CHINA
8.1 China Intravenous Immune Globulin Therapies Market Size (2015-2020)
8.2 Intravenous Immune Globulin Therapies Key Players in China (2019-2020)
8.3 China Intravenous Immune Globulin Therapies Market Size by Type (2015-2020)
8.4 China Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Intravenous Immune Globulin Therapies Market Size (2015-2020)
9.2 Intravenous Immune Globulin Therapies Key Players in Japan (2019-2020)
9.3 Japan Intravenous Immune Globulin Therapies Market Size by Type (2015-2020)
9.4 Japan Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Intravenous Immune Globulin Therapies Market Size (2015-2020)
10.2 Intravenous Immune Globulin Therapies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Intravenous Immune Globulin Therapies Market Size by Type (2015-2020)
10.4 Southeast Asia Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
11 INDIA
11.1 India Intravenous Immune Globulin Therapies Market Size (2015-2020)
11.2 Intravenous Immune Globulin Therapies Key Players in India (2019-2020)
11.3 India Intravenous Immune Globulin Therapies Market Size by Type (2015-2020)
11.4 India Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Intravenous Immune Globulin Therapies Market Size (2015-2020)
12.2 Intravenous Immune Globulin Therapies Key Players in Central & South America (2019-2020)
12.3 Central & South America Intravenous Immune Globulin Therapies Market Size by Type (2015-2020)
12.4 Central & South America Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Baxter
13.1.1 Baxter Company Details
13.1.2 Baxter Business Overview and Its Total Revenue
13.1.3 Baxter Intravenous Immune Globulin Therapies Introduction
13.1.4 Baxter Revenue in Intravenous Immune Globulin Therapies Business (2015-2020))
13.1.5 Baxter Recent Development
13.2 Grifols
13.2.1 Grifols Company Details
13.2.2 Grifols Business Overview and Its Total Revenue
13.2.3 Grifols Intravenous Immune Globulin Therapies Introduction
13.2.4 Grifols Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
13.2.5 Grifols Recent Development
13.3 CSL Plasma
13.3.1 CSL Plasma Company Details
13.3.2 CSL Plasma Business Overview and Its Total Revenue
13.3.3 CSL Plasma Intravenous Immune Globulin Therapies Introduction
13.3.4 CSL Plasma Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
13.3.5 CSL Plasma Recent Development
13.4 Octapharma
13.4.1 Octapharma Company Details
13.4.2 Octapharma Business Overview and Its Total Revenue
13.4.3 Octapharma Intravenous Immune Globulin Therapies Introduction
13.4.4 Octapharma Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
13.4.5 Octapharma Recent Development
13.5 Biotest
13.5.1 Biotest Company Details
13.5.2 Biotest Business Overview and Its Total Revenue
13.5.3 Biotest Intravenous Immune Globulin Therapies Introduction
13.5.4 Biotest Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
13.5.5 Biotest Recent Development
13.6 Kedrion
13.6.1 Kedrion Company Details
13.6.2 Kedrion Business Overview and Its Total Revenue
13.6.3 Kedrion Intravenous Immune Globulin Therapies Introduction
13.6.4 Kedrion Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
13.6.5 Kedrion Recent Development
13.7 Kamada
13.7.1 Kamada Company Details
13.7.2 Kamada Business Overview and Its Total Revenue
13.7.3 Kamada Intravenous Immune Globulin Therapies Introduction
13.7.4 Kamada Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
13.7.5 Kamada Recent Development
13.8 China Biologic Products Holdings
13.8.1 China Biologic Products Holdings Company Details
13.8.2 China Biologic Products Holdings Business Overview and Its Total Revenue
13.8.3 China Biologic Products Holdings Intravenous Immune Globulin Therapies Introduction
13.8.4 China Biologic Products Holdings Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
13.8.5 China Biologic Products Holdings Recent Development
13.9 Hualan Biological Engineering
13.9.1 Hualan Biological Engineering Company Details
13.9.2 Hualan Biological Engineering Business Overview and Its Total Revenue
13.9.3 Hualan Biological Engineering Intravenous Immune Globulin Therapies Introduction
13.9.4 Hualan Biological Engineering Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
13.9.5 Hualan Biological Engineering Recent Development
13.10 Sichuan Yuanda Shuyang Pharmaceutical
13.10.1 Sichuan Yuanda Shuyang Pharmaceutical Company Details
13.10.2 Sichuan Yuanda Shuyang Pharmaceutical Business Overview and Its Total Revenue
13.10.3 Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Introduction
13.10.4 Sichuan Yuanda Shuyang Pharmaceutical Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
13.10.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Intravenous Immune Globulin Therapies Revenue
1.4 Market Analysis by Type
1.4.1 Global Intravenous Immune Globulin Therapies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Liquid Form
1.4.3 Lyophilized Powder Form
1.5 Market by Application
1.5.1 Global Intravenous Immune Globulin Therapies Market Share by Application: 2020 VS 2026
1.5.2 Immunodeficiency
1.5.3 Autoimmune Disease
1.5.4 Acute Infection
1.6 Coronavirus Disease 2019 (Covid-19): Intravenous Immune Globulin Therapies Industry Impact
1.6.1 How the Covid-19 is Affecting the Intravenous Immune Globulin Therapies Industry
1.6.1.1 Intravenous Immune Globulin Therapies Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Intravenous Immune Globulin Therapies Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Intravenous Immune Globulin Therapies Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Intravenous Immune Globulin Therapies Market Perspective (2015-2026)
2.2 Intravenous Immune Globulin Therapies Growth Trends by Regions
2.2.1 Intravenous Immune Globulin Therapies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Intravenous Immune Globulin Therapies Historic Market Share by Regions (2015-2020)
2.2.3 Intravenous Immune Globulin Therapies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Intravenous Immune Globulin Therapies Market Growth Strategy
2.3.6 Primary Interviews with Key Intravenous Immune Globulin Therapies Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Intravenous Immune Globulin Therapies Players by Market Size
3.1.1 Global Top Intravenous Immune Globulin Therapies Players by Revenue (2015-2020)
3.1.2 Global Intravenous Immune Globulin Therapies Revenue Market Share by Players (2015-2020)
3.1.3 Global Intravenous Immune Globulin Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Intravenous Immune Globulin Therapies Market Concentration Ratio
3.2.1 Global Intravenous Immune Globulin Therapies Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Intravenous Immune Globulin Therapies Revenue in 2019
3.3 Intravenous Immune Globulin Therapies Key Players Head office and Area Served
3.4 Key Players Intravenous Immune Globulin Therapies Product Solution and Service
3.5 Date of Enter into Intravenous Immune Globulin Therapies Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Intravenous Immune Globulin Therapies Historic Market Size by Type (2015-2020)
4.2 Global Intravenous Immune Globulin Therapies Forecasted Market Size by Type (2021-2026)
5 INTRAVENOUS IMMUNE GLOBULIN THERAPIES BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
5.2 Global Intravenous Immune Globulin Therapies Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Intravenous Immune Globulin Therapies Market Size (2015-2020)
6.2 Intravenous Immune Globulin Therapies Key Players in North America (2019-2020)
6.3 North America Intravenous Immune Globulin Therapies Market Size by Type (2015-2020)
6.4 North America Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Intravenous Immune Globulin Therapies Market Size (2015-2020)
7.2 Intravenous Immune Globulin Therapies Key Players in Europe (2019-2020)
7.3 Europe Intravenous Immune Globulin Therapies Market Size by Type (2015-2020)
7.4 Europe Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
8 CHINA
8.1 China Intravenous Immune Globulin Therapies Market Size (2015-2020)
8.2 Intravenous Immune Globulin Therapies Key Players in China (2019-2020)
8.3 China Intravenous Immune Globulin Therapies Market Size by Type (2015-2020)
8.4 China Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Intravenous Immune Globulin Therapies Market Size (2015-2020)
9.2 Intravenous Immune Globulin Therapies Key Players in Japan (2019-2020)
9.3 Japan Intravenous Immune Globulin Therapies Market Size by Type (2015-2020)
9.4 Japan Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Intravenous Immune Globulin Therapies Market Size (2015-2020)
10.2 Intravenous Immune Globulin Therapies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Intravenous Immune Globulin Therapies Market Size by Type (2015-2020)
10.4 Southeast Asia Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
11 INDIA
11.1 India Intravenous Immune Globulin Therapies Market Size (2015-2020)
11.2 Intravenous Immune Globulin Therapies Key Players in India (2019-2020)
11.3 India Intravenous Immune Globulin Therapies Market Size by Type (2015-2020)
11.4 India Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Intravenous Immune Globulin Therapies Market Size (2015-2020)
12.2 Intravenous Immune Globulin Therapies Key Players in Central & South America (2019-2020)
12.3 Central & South America Intravenous Immune Globulin Therapies Market Size by Type (2015-2020)
12.4 Central & South America Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Baxter
13.1.1 Baxter Company Details
13.1.2 Baxter Business Overview and Its Total Revenue
13.1.3 Baxter Intravenous Immune Globulin Therapies Introduction
13.1.4 Baxter Revenue in Intravenous Immune Globulin Therapies Business (2015-2020))
13.1.5 Baxter Recent Development
13.2 Grifols
13.2.1 Grifols Company Details
13.2.2 Grifols Business Overview and Its Total Revenue
13.2.3 Grifols Intravenous Immune Globulin Therapies Introduction
13.2.4 Grifols Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
13.2.5 Grifols Recent Development
13.3 CSL Plasma
13.3.1 CSL Plasma Company Details
13.3.2 CSL Plasma Business Overview and Its Total Revenue
13.3.3 CSL Plasma Intravenous Immune Globulin Therapies Introduction
13.3.4 CSL Plasma Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
13.3.5 CSL Plasma Recent Development
13.4 Octapharma
13.4.1 Octapharma Company Details
13.4.2 Octapharma Business Overview and Its Total Revenue
13.4.3 Octapharma Intravenous Immune Globulin Therapies Introduction
13.4.4 Octapharma Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
13.4.5 Octapharma Recent Development
13.5 Biotest
13.5.1 Biotest Company Details
13.5.2 Biotest Business Overview and Its Total Revenue
13.5.3 Biotest Intravenous Immune Globulin Therapies Introduction
13.5.4 Biotest Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
13.5.5 Biotest Recent Development
13.6 Kedrion
13.6.1 Kedrion Company Details
13.6.2 Kedrion Business Overview and Its Total Revenue
13.6.3 Kedrion Intravenous Immune Globulin Therapies Introduction
13.6.4 Kedrion Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
13.6.5 Kedrion Recent Development
13.7 Kamada
13.7.1 Kamada Company Details
13.7.2 Kamada Business Overview and Its Total Revenue
13.7.3 Kamada Intravenous Immune Globulin Therapies Introduction
13.7.4 Kamada Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
13.7.5 Kamada Recent Development
13.8 China Biologic Products Holdings
13.8.1 China Biologic Products Holdings Company Details
13.8.2 China Biologic Products Holdings Business Overview and Its Total Revenue
13.8.3 China Biologic Products Holdings Intravenous Immune Globulin Therapies Introduction
13.8.4 China Biologic Products Holdings Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
13.8.5 China Biologic Products Holdings Recent Development
13.9 Hualan Biological Engineering
13.9.1 Hualan Biological Engineering Company Details
13.9.2 Hualan Biological Engineering Business Overview and Its Total Revenue
13.9.3 Hualan Biological Engineering Intravenous Immune Globulin Therapies Introduction
13.9.4 Hualan Biological Engineering Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
13.9.5 Hualan Biological Engineering Recent Development
13.10 Sichuan Yuanda Shuyang Pharmaceutical
13.10.1 Sichuan Yuanda Shuyang Pharmaceutical Company Details
13.10.2 Sichuan Yuanda Shuyang Pharmaceutical Business Overview and Its Total Revenue
13.10.3 Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Introduction
13.10.4 Sichuan Yuanda Shuyang Pharmaceutical Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
13.10.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Intravenous Immune Globulin Therapies Key Market Segments
Table 2. Key Players Covered: Ranking by Intravenous Immune Globulin Therapies Revenue
Table 3. Ranking of Global Top Intravenous Immune Globulin Therapies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Intravenous Immune Globulin Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Liquid Form
Table 6. Key Players of Lyophilized Powder Form
Table 7. COVID-19 Impact Global Market: (Four Intravenous Immune Globulin Therapies Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Intravenous Immune Globulin Therapies Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Intravenous Immune Globulin Therapies Players to Combat Covid-19 Impact
Table 12. Global Intravenous Immune Globulin Therapies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Intravenous Immune Globulin Therapies Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Intravenous Immune Globulin Therapies Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Intravenous Immune Globulin Therapies Market Share by Regions (2015-2020)
Table 16. Global Intravenous Immune Globulin Therapies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Intravenous Immune Globulin Therapies Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Intravenous Immune Globulin Therapies Market Growth Strategy
Table 22. Main Points Interviewed from Key Intravenous Immune Globulin Therapies Players
Table 23. Global Intravenous Immune Globulin Therapies Revenue by Players (2015-2020) (Million US$)
Table 24. Global Intravenous Immune Globulin Therapies Market Share by Players (2015-2020)
Table 25. Global Top Intravenous Immune Globulin Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Immune Globulin Therapies as of 2019)
Table 26. Global Intravenous Immune Globulin Therapies by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Intravenous Immune Globulin Therapies Product Solution and Service
Table 29. Date of Enter into Intravenous Immune Globulin Therapies Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Intravenous Immune Globulin Therapies Market Size by Type (2015-2020) (Million US$)
Table 32. Global Intravenous Immune Globulin Therapies Market Size Share by Type (2015-2020)
Table 33. Global Intravenous Immune Globulin Therapies Revenue Market Share by Type (2021-2026)
Table 34. Global Intravenous Immune Globulin Therapies Market Size Share by Application (2015-2020)
Table 35. Global Intravenous Immune Globulin Therapies Market Size by Application (2015-2020) (Million US$)
Table 36. Global Intravenous Immune Globulin Therapies Market Size Share by Application (2021-2026)
Table 37. North America Key Players Intravenous Immune Globulin Therapies Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Intravenous Immune Globulin Therapies Market Share (2019-2020)
Table 39. North America Intravenous Immune Globulin Therapies Market Size by Type (2015-2020) (Million US$)
Table 40. North America Intravenous Immune Globulin Therapies Market Share by Type (2015-2020)
Table 41. North America Intravenous Immune Globulin Therapies Market Size by Application (2015-2020) (Million US$)
Table 42. North America Intravenous Immune Globulin Therapies Market Share by Application (2015-2020)
Table 43. Europe Key Players Intravenous Immune Globulin Therapies Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Intravenous Immune Globulin Therapies Market Share (2019-2020)
Table 45. Europe Intravenous Immune Globulin Therapies Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Intravenous Immune Globulin Therapies Market Share by Type (2015-2020)
Table 47. Europe Intravenous Immune Globulin Therapies Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Intravenous Immune Globulin Therapies Market Share by Application (2015-2020)
Table 49. China Key Players Intravenous Immune Globulin Therapies Revenue (2019-2020) (Million US$)
Table 50. China Key Players Intravenous Immune Globulin Therapies Market Share (2019-2020)
Table 51. China Intravenous Immune Globulin Therapies Market Size by Type (2015-2020) (Million US$)
Table 52. China Intravenous Immune Globulin Therapies Market Share by Type (2015-2020)
Table 53. China Intravenous Immune Globulin Therapies Market Size by Application (2015-2020) (Million US$)
Table 54. China Intravenous Immune Globulin Therapies Market Share by Application (2015-2020)
Table 55. Japan Key Players Intravenous Immune Globulin Therapies Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Intravenous Immune Globulin Therapies Market Share (2019-2020)
Table 57. Japan Intravenous Immune Globulin Therapies Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Intravenous Immune Globulin Therapies Market Share by Type (2015-2020)
Table 59. Japan Intravenous Immune Globulin Therapies Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Intravenous Immune Globulin Therapies Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Intravenous Immune Globulin Therapies Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Intravenous Immune Globulin Therapies Market Share (2019-2020)
Table 63. Southeast Asia Intravenous Immune Globulin Therapies Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Intravenous Immune Globulin Therapies Market Share by Type (2015-2020)
Table 65. Southeast Asia Intravenous Immune Globulin Therapies Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Intravenous Immune Globulin Therapies Market Share by Application (2015-2020)
Table 67. India Key Players Intravenous Immune Globulin Therapies Revenue (2019-2020) (Million US$)
Table 68. India Key Players Intravenous Immune Globulin Therapies Market Share (2019-2020)
Table 69. India Intravenous Immune Globulin Therapies Market Size by Type (2015-2020) (Million US$)
Table 70. India Intravenous Immune Globulin Therapies Market Share by Type (2015-2020)
Table 71. India Intravenous Immune Globulin Therapies Market Size by Application (2015-2020) (Million US$)
Table 72. India Intravenous Immune Globulin Therapies Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Intravenous Immune Globulin Therapies Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Intravenous Immune Globulin Therapies Market Share (2019-2020)
Table 75. Central & South America Intravenous Immune Globulin Therapies Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Intravenous Immune Globulin Therapies Market Share by Type (2015-2020)
Table 77. Central & South America Intravenous Immune Globulin Therapies Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Intravenous Immune Globulin Therapies Market Share by Application (2015-2020)
Table 79. Baxter Company Details
Table 80. Baxter Business Overview
Table 81. Baxter Product
Table 82. Baxter Revenue in Intravenous Immune Globulin Therapies Business (2015-2020) (Million US$)
Table 83. Baxter Recent Development
Table 84. Grifols Company Details
Table 85. Grifols Business Overview
Table 86. Grifols Product
Table 87. Grifols Revenue in Intravenous Immune Globulin Therapies Business (2015-2020) (Million US$)
Table 88. Grifols Recent Development
Table 89. CSL Plasma Company Details
Table 90. CSL Plasma Business Overview
Table 91. CSL Plasma Product
Table 92. CSL Plasma Revenue in Intravenous Immune Globulin Therapies Business (2015-2020) (Million US$)
Table 93. CSL Plasma Recent Development
Table 94. Octapharma Company Details
Table 95. Octapharma Business Overview
Table 96. Octapharma Product
Table 97. Octapharma Revenue in Intravenous Immune Globulin Therapies Business (2015-2020) (Million US$)
Table 98. Octapharma Recent Development
Table 99. Biotest Company Details
Table 100. Biotest Business Overview
Table 101. Biotest Product
Table 102. Biotest Revenue in Intravenous Immune Globulin Therapies Business (2015-2020) (Million US$)
Table 103. Biotest Recent Development
Table 104. Kedrion Company Details
Table 105. Kedrion Business Overview
Table 106. Kedrion Product
Table 107. Kedrion Revenue in Intravenous Immune Globulin Therapies Business (2015-2020) (Million US$)
Table 108. Kedrion Recent Development
Table 109. Kamada Company Details
Table 110. Kamada Business Overview
Table 111. Kamada Product
Table 112. Kamada Revenue in Intravenous Immune Globulin Therapies Business (2015-2020) (Million US$)
Table 113. Kamada Recent Development
Table 114. China Biologic Products Holdings Business Overview
Table 115. China Biologic Products Holdings Product
Table 116. China Biologic Products Holdings Company Details
Table 117. China Biologic Products Holdings Revenue in Intravenous Immune Globulin Therapies Business (2015-2020) (Million US$)
Table 118. China Biologic Products Holdings Recent Development
Table 119. Hualan Biological Engineering Company Details
Table 120. Hualan Biological Engineering Business Overview
Table 121. Hualan Biological Engineering Product
Table 122. Hualan Biological Engineering Revenue in Intravenous Immune Globulin Therapies Business (2015-2020) (Million US$)
Table 123. Hualan Biological Engineering Recent Development
Table 124. Sichuan Yuanda Shuyang Pharmaceutical Company Details
Table 125. Sichuan Yuanda Shuyang Pharmaceutical Business Overview
Table 126. Sichuan Yuanda Shuyang Pharmaceutical Product
Table 127. Sichuan Yuanda Shuyang Pharmaceutical Revenue in Intravenous Immune Globulin Therapies Business (2015-2020) (Million US$)
Table 128. Sichuan Yuanda Shuyang Pharmaceutical Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
Table 1. Intravenous Immune Globulin Therapies Key Market Segments
Table 2. Key Players Covered: Ranking by Intravenous Immune Globulin Therapies Revenue
Table 3. Ranking of Global Top Intravenous Immune Globulin Therapies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Intravenous Immune Globulin Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Liquid Form
Table 6. Key Players of Lyophilized Powder Form
Table 7. COVID-19 Impact Global Market: (Four Intravenous Immune Globulin Therapies Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Intravenous Immune Globulin Therapies Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Intravenous Immune Globulin Therapies Players to Combat Covid-19 Impact
Table 12. Global Intravenous Immune Globulin Therapies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Intravenous Immune Globulin Therapies Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Intravenous Immune Globulin Therapies Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Intravenous Immune Globulin Therapies Market Share by Regions (2015-2020)
Table 16. Global Intravenous Immune Globulin Therapies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Intravenous Immune Globulin Therapies Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Intravenous Immune Globulin Therapies Market Growth Strategy
Table 22. Main Points Interviewed from Key Intravenous Immune Globulin Therapies Players
Table 23. Global Intravenous Immune Globulin Therapies Revenue by Players (2015-2020) (Million US$)
Table 24. Global Intravenous Immune Globulin Therapies Market Share by Players (2015-2020)
Table 25. Global Top Intravenous Immune Globulin Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Immune Globulin Therapies as of 2019)
Table 26. Global Intravenous Immune Globulin Therapies by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Intravenous Immune Globulin Therapies Product Solution and Service
Table 29. Date of Enter into Intravenous Immune Globulin Therapies Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Intravenous Immune Globulin Therapies Market Size by Type (2015-2020) (Million US$)
Table 32. Global Intravenous Immune Globulin Therapies Market Size Share by Type (2015-2020)
Table 33. Global Intravenous Immune Globulin Therapies Revenue Market Share by Type (2021-2026)
Table 34. Global Intravenous Immune Globulin Therapies Market Size Share by Application (2015-2020)
Table 35. Global Intravenous Immune Globulin Therapies Market Size by Application (2015-2020) (Million US$)
Table 36. Global Intravenous Immune Globulin Therapies Market Size Share by Application (2021-2026)
Table 37. North America Key Players Intravenous Immune Globulin Therapies Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Intravenous Immune Globulin Therapies Market Share (2019-2020)
Table 39. North America Intravenous Immune Globulin Therapies Market Size by Type (2015-2020) (Million US$)
Table 40. North America Intravenous Immune Globulin Therapies Market Share by Type (2015-2020)
Table 41. North America Intravenous Immune Globulin Therapies Market Size by Application (2015-2020) (Million US$)
Table 42. North America Intravenous Immune Globulin Therapies Market Share by Application (2015-2020)
Table 43. Europe Key Players Intravenous Immune Globulin Therapies Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Intravenous Immune Globulin Therapies Market Share (2019-2020)
Table 45. Europe Intravenous Immune Globulin Therapies Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Intravenous Immune Globulin Therapies Market Share by Type (2015-2020)
Table 47. Europe Intravenous Immune Globulin Therapies Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Intravenous Immune Globulin Therapies Market Share by Application (2015-2020)
Table 49. China Key Players Intravenous Immune Globulin Therapies Revenue (2019-2020) (Million US$)
Table 50. China Key Players Intravenous Immune Globulin Therapies Market Share (2019-2020)
Table 51. China Intravenous Immune Globulin Therapies Market Size by Type (2015-2020) (Million US$)
Table 52. China Intravenous Immune Globulin Therapies Market Share by Type (2015-2020)
Table 53. China Intravenous Immune Globulin Therapies Market Size by Application (2015-2020) (Million US$)
Table 54. China Intravenous Immune Globulin Therapies Market Share by Application (2015-2020)
Table 55. Japan Key Players Intravenous Immune Globulin Therapies Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Intravenous Immune Globulin Therapies Market Share (2019-2020)
Table 57. Japan Intravenous Immune Globulin Therapies Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Intravenous Immune Globulin Therapies Market Share by Type (2015-2020)
Table 59. Japan Intravenous Immune Globulin Therapies Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Intravenous Immune Globulin Therapies Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Intravenous Immune Globulin Therapies Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Intravenous Immune Globulin Therapies Market Share (2019-2020)
Table 63. Southeast Asia Intravenous Immune Globulin Therapies Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Intravenous Immune Globulin Therapies Market Share by Type (2015-2020)
Table 65. Southeast Asia Intravenous Immune Globulin Therapies Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Intravenous Immune Globulin Therapies Market Share by Application (2015-2020)
Table 67. India Key Players Intravenous Immune Globulin Therapies Revenue (2019-2020) (Million US$)
Table 68. India Key Players Intravenous Immune Globulin Therapies Market Share (2019-2020)
Table 69. India Intravenous Immune Globulin Therapies Market Size by Type (2015-2020) (Million US$)
Table 70. India Intravenous Immune Globulin Therapies Market Share by Type (2015-2020)
Table 71. India Intravenous Immune Globulin Therapies Market Size by Application (2015-2020) (Million US$)
Table 72. India Intravenous Immune Globulin Therapies Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Intravenous Immune Globulin Therapies Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Intravenous Immune Globulin Therapies Market Share (2019-2020)
Table 75. Central & South America Intravenous Immune Globulin Therapies Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Intravenous Immune Globulin Therapies Market Share by Type (2015-2020)
Table 77. Central & South America Intravenous Immune Globulin Therapies Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Intravenous Immune Globulin Therapies Market Share by Application (2015-2020)
Table 79. Baxter Company Details
Table 80. Baxter Business Overview
Table 81. Baxter Product
Table 82. Baxter Revenue in Intravenous Immune Globulin Therapies Business (2015-2020) (Million US$)
Table 83. Baxter Recent Development
Table 84. Grifols Company Details
Table 85. Grifols Business Overview
Table 86. Grifols Product
Table 87. Grifols Revenue in Intravenous Immune Globulin Therapies Business (2015-2020) (Million US$)
Table 88. Grifols Recent Development
Table 89. CSL Plasma Company Details
Table 90. CSL Plasma Business Overview
Table 91. CSL Plasma Product
Table 92. CSL Plasma Revenue in Intravenous Immune Globulin Therapies Business (2015-2020) (Million US$)
Table 93. CSL Plasma Recent Development
Table 94. Octapharma Company Details
Table 95. Octapharma Business Overview
Table 96. Octapharma Product
Table 97. Octapharma Revenue in Intravenous Immune Globulin Therapies Business (2015-2020) (Million US$)
Table 98. Octapharma Recent Development
Table 99. Biotest Company Details
Table 100. Biotest Business Overview
Table 101. Biotest Product
Table 102. Biotest Revenue in Intravenous Immune Globulin Therapies Business (2015-2020) (Million US$)
Table 103. Biotest Recent Development
Table 104. Kedrion Company Details
Table 105. Kedrion Business Overview
Table 106. Kedrion Product
Table 107. Kedrion Revenue in Intravenous Immune Globulin Therapies Business (2015-2020) (Million US$)
Table 108. Kedrion Recent Development
Table 109. Kamada Company Details
Table 110. Kamada Business Overview
Table 111. Kamada Product
Table 112. Kamada Revenue in Intravenous Immune Globulin Therapies Business (2015-2020) (Million US$)
Table 113. Kamada Recent Development
Table 114. China Biologic Products Holdings Business Overview
Table 115. China Biologic Products Holdings Product
Table 116. China Biologic Products Holdings Company Details
Table 117. China Biologic Products Holdings Revenue in Intravenous Immune Globulin Therapies Business (2015-2020) (Million US$)
Table 118. China Biologic Products Holdings Recent Development
Table 119. Hualan Biological Engineering Company Details
Table 120. Hualan Biological Engineering Business Overview
Table 121. Hualan Biological Engineering Product
Table 122. Hualan Biological Engineering Revenue in Intravenous Immune Globulin Therapies Business (2015-2020) (Million US$)
Table 123. Hualan Biological Engineering Recent Development
Table 124. Sichuan Yuanda Shuyang Pharmaceutical Company Details
Table 125. Sichuan Yuanda Shuyang Pharmaceutical Business Overview
Table 126. Sichuan Yuanda Shuyang Pharmaceutical Product
Table 127. Sichuan Yuanda Shuyang Pharmaceutical Revenue in Intravenous Immune Globulin Therapies Business (2015-2020) (Million US$)
Table 128. Sichuan Yuanda Shuyang Pharmaceutical Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Intravenous Immune Globulin Therapies Market Share by Type: 2020 VS 2026
Figure 2. Liquid Form Features
Figure 3. Lyophilized Powder Form Features
Figure 4. Global Intravenous Immune Globulin Therapies Market Share by Application: 2020 VS 2026
Figure 5. Immunodeficiency Case Studies
Figure 6. Autoimmune Disease Case Studies
Figure 7. Acute Infection Case Studies
Figure 8. Intravenous Immune Globulin Therapies Report Years Considered
Figure 9. Global Intravenous Immune Globulin Therapies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Intravenous Immune Globulin Therapies Market Share by Regions: 2020 VS 2026
Figure 11. Global Intravenous Immune Globulin Therapies Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Intravenous Immune Globulin Therapies Market Share by Players in 2019
Figure 14. Global Top Intravenous Immune Globulin Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Immune Globulin Therapies as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Intravenous Immune Globulin Therapies Revenue in 2019
Figure 16. North America Intravenous Immune Globulin Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Intravenous Immune Globulin Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Intravenous Immune Globulin Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Intravenous Immune Globulin Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Intravenous Immune Globulin Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Intravenous Immune Globulin Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Intravenous Immune Globulin Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Baxter Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2015-2020)
Figure 25. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Grifols Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2015-2020)
Figure 27. CSL Plasma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. CSL Plasma Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2015-2020)
Figure 29. Octapharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Octapharma Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2015-2020)
Figure 31. Biotest Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Biotest Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2015-2020)
Figure 33. Kedrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Kedrion Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2015-2020)
Figure 35. Kamada Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Kamada Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2015-2020)
Figure 37. China Biologic Products Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. China Biologic Products Holdings Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2015-2020)
Figure 39. Hualan Biological Engineering Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Hualan Biological Engineering Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2015-2020)
Figure 41. Sichuan Yuanda Shuyang Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Sichuan Yuanda Shuyang Pharmaceutical Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2015-2020)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
Figure 1. Global Intravenous Immune Globulin Therapies Market Share by Type: 2020 VS 2026
Figure 2. Liquid Form Features
Figure 3. Lyophilized Powder Form Features
Figure 4. Global Intravenous Immune Globulin Therapies Market Share by Application: 2020 VS 2026
Figure 5. Immunodeficiency Case Studies
Figure 6. Autoimmune Disease Case Studies
Figure 7. Acute Infection Case Studies
Figure 8. Intravenous Immune Globulin Therapies Report Years Considered
Figure 9. Global Intravenous Immune Globulin Therapies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Intravenous Immune Globulin Therapies Market Share by Regions: 2020 VS 2026
Figure 11. Global Intravenous Immune Globulin Therapies Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Intravenous Immune Globulin Therapies Market Share by Players in 2019
Figure 14. Global Top Intravenous Immune Globulin Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Immune Globulin Therapies as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Intravenous Immune Globulin Therapies Revenue in 2019
Figure 16. North America Intravenous Immune Globulin Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Intravenous Immune Globulin Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Intravenous Immune Globulin Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Intravenous Immune Globulin Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Intravenous Immune Globulin Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Intravenous Immune Globulin Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Intravenous Immune Globulin Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Baxter Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2015-2020)
Figure 25. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Grifols Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2015-2020)
Figure 27. CSL Plasma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. CSL Plasma Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2015-2020)
Figure 29. Octapharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Octapharma Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2015-2020)
Figure 31. Biotest Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Biotest Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2015-2020)
Figure 33. Kedrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Kedrion Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2015-2020)
Figure 35. Kamada Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Kamada Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2015-2020)
Figure 37. China Biologic Products Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. China Biologic Products Holdings Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2015-2020)
Figure 39. Hualan Biological Engineering Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Hualan Biological Engineering Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2015-2020)
Figure 41. Sichuan Yuanda Shuyang Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Sichuan Yuanda Shuyang Pharmaceutical Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2015-2020)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
